NCT03216564View on ClinicalTrials.gov

An Intervention to Examine the Effect of Vitamin D on Urine Protein Levels in Type 2 Diabetes

PHASE3UnknownINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

May 10, 2017

Primary Completion Date

May 10, 2019

Study Completion Date

May 10, 2019

Conditions
Diabetic Nephropathies
Interventions
DRUG

Calcitriol

Active vitamin D (Calcitriol) 0.25 micrograms

Trial Locations (1)

Unknown

RECRUITING

Hamad Medical Corporation, Doha

Sponsors
All Listed Sponsors
collaborator

Weill Cornell Medical College in Qatar

OTHER

lead

Hamad Medical Corporation

INDUSTRY

NCT03216564 - An Intervention to Examine the Effect of Vitamin D on Urine Protein Levels in Type 2 Diabetes | Biotech Hunter | Biotech Hunter